🔴 IMPORTANT: Read This Before Proceeding With Dosing
Go to the Prep & Injection Guide for proper reconstitution, syringe sizing, and injection protocols. Mistakes here can compromise your research.

👉 Click here to read the Prep & Injection Guide

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that stimulates the release of human growth hormone (HGH). FDA-approved for body fat redistribution syndrome, Tesamorelin has shown powerful effects on fat loss, muscle preservation, nerve regeneration, and cognitive enhancement.

It is not a steroid and does not affect testosterone levels.

BENEFITS

  • Reduces adipose fat tissue (especially in the abdomen and upper back)
  • Targets visceral fat around internal organs (liver, stomach, intestines)
  • Preserves and increases lean muscle mass
  • Boosts metabolism and energy output
  • Reduces cholesterol and triglycerides
  • Supports nerve regeneration after injury
  • Increases neurotransmitters tied to cognitive performance

TESAMORELIN AND GELLING: IS THIS INDICATIVE OF DEGRADATION? WHY DOES IT HAPPEN?

Tesamorelin is a synthetic 44-amino-acid analog of growth hormone releasing hormone, GHRH(1-44), carrying an N-terminal trans-3-hexenoyl modification (the (3E)-hex-3-enoyl / N-((3E)-1-oxo-3-hexenyl)somatoliberin cap) reported to improve stability relative to native GHRH. Its identity is confirmed against PubChem CID 16137828 (molecular formula C221H366N72O67S, average molecular weight approximately 5136 g/mol) and NCBI LiverTox monograph NBK548730. This page addresses a common bench observation with this peptide: cloudiness, incomplete dissolution, or a gel-like mass forming during reconstitution.

Gelling and clumping are reported as a solubility and pH phenomenon rather than, on their own, evidence of chemical degradation. Tesamorelin’s isoelectric point sits near neutral pH and its lipophilic hexenoyl cap adds hydrophobic character, so near-neutral diluents can favor molecule-to-molecule association over dissolution. Understanding that dynamic is the key to choosing a diluent and a mixing technique that keep the material in solution.

The guidance below describes handling of a research-use-only material in laboratory settings only. It is not a statement of any human or veterinary use, dose, or effect. All handling values here are drawn from research-supplier guidance and general peptide-chemistry sources rather than a stability study on any specific lot, so batch-specific parameters should always be confirmed against the Certificate of Analysis (COA).

Mechanisms reported in the in-vitro and preclinical research literature include:

  • The observed gelling has a straightforward physicochemical basis. A peptide is most soluble when its molecules carry net charge, because like-charged molecules repel one another and stay dispersed in solvent. At or very near a peptide’s isoelectric point (pI), the net charge approaches zero, charge-charge repulsion is lost, and attractive forces (including hydrophobic association) begin to dominate.
  • Tesamorelin’s pI is described qualitatively as near neutral by handling sources, and its N-terminal hexenoyl cap adds lipophilic, hydrophobic character to the molecule. When it is added to a plain, near-neutral diluent such as unbuffered bacteriostatic or sterile water, the local pH can sit close to that pI. With repulsion minimized and hydrophobic surfaces exposed, molecules associate rather than dissolve, and the result is cloudiness, slow or incomplete dissolution, or a gel-like clump. Higher peptide concentrations make this more likely because more molecules are present to associate.
  • The practical lever is pH. Shifting the solution away from the pI, into slightly acidic territory, restores net positive charge on the peptide and the repulsion that keeps molecules apart, which is why dilute-acid diluents are reported to dissolve tesamorelin more cleanly than plain water. A definitive measured pI for tesamorelin was not retrieved this run, so the specific numeric value is described only qualitatively here; confirm any lot-specific solubility parameters against the batch COA.

POSSIBLE SIDE EFFECTS

  • Injection site irritation (redness, swelling, itching)
  • Muscle aches and pain
  • Headache
  • Nausea
  • Diarrhea
  • Sweating
  • Carpal tunnel symptoms
  • Edema
  • Fluid retention

RARE BUT SERIOUS SIDE EFFECTS

  • Diarrhea with fever and dehydration
  • Shortness of breath
  • Joint or muscle pain
  • Numbness or tingling in the extremities
  • May increase risk of Type-2 diabetes

INTERACTIONS

Tirzepatide and Tesamorelin should only be used together under close medical supervision for diabetics, due to the fact that they have opposing effects on blood glucose levels, which may reduce the effectiveness of diabetes management. Tesamorelin tends to raise blood sugar, while tirzepatide lowers it, potentially leading to unpredictable glucose control. In addition to the concerns regarding diabetics, taking Tesamorelin with Tirzepatide may make the Tirzepatide less effective.

CONTRAINDICATIONS

Do not use Tesamorelin if:

  • You’ve had pituitary tumors or surgery
  • You have an active malignancy
  • You’re allergic to mannitol
  • You’re pregnant or breastfeeding
  • You’ve had hypothalamic-pituitary axis disruption
  • You have a diagnosed pituitary disorder

DOSING

CYCLING: 12-16 week cycle followed by 4-8 week washout period. Shorter cycles will not yield tangible results- do not begin this product with the intention of “trying it out” for 3 or 4 weeks. This will not be effective. Each week should consist of 5 consecutive dosing days followed by 2
“rest” days.

TIMING: Dose at night, at least 90 minutes after your last meal.

RECONSTITUTION SOLUTION(S):

Hospira brand BAC water preferred (many companies do not maintain a known, consistent pH level like Hospira does)

.6% Acetic Acid Solution

Hospira brand BAC water is preferred because of the absolute consistency of its pH level- if the BAC water is a bit too acidic or too basic, peptides can lose their electrical charge, causing them to clump together. Extreme pH differences can denature the peptide, altering its structure and potentially rendering it ineffective.

An acetic acid solution is required to help prevent the product from gelling.

ADMINISTRATION: Subcutaneous Injection

IMPORTANT NOTE CONCERNING POST-RECONSTITUTION STORAGE OF TESAMORELIN

Store at room temperature, in a dry, dark location. This helps to prevent the peptide from gelling. Please note that storage at this temperature drastically decreases the length of time that you have to finish the vial.

SPECIFIC RECOMMENDATIONS FOR THE RECONSTITUTION OF TESAMORELIN TO PREVENT GELLING

  • Always bring the vial to room temperature before reconstituting. Acetic acid solution and bacteriostatic water must also be at room temperature prior to mixing. Opening a cold vial invites condensation onto the freeze-dried cake, which introduces uncontrolled water and can start localized, uneven wetting of the powder. Do not force warming with heat sources. Let the vial equilibrate passively. The goal is simply that vial and cake are no longer cold when diluent is introduced.
  • Choose a diluent that shifts pH off the isoelectric point. Plain near-neutral water sits close to tesamorelin’s reported near-neutral pI, which is exactly the condition that promotes association and gelling. Reported bench practice favors sterile water for injection, or a dilute acetic acid solution in sterile water (on the order of 0.1% to 1% acetic acid), to move the pH into slightly acidic territory and maximize solubility. Dilute acid is also reported to reduce methionine oxidation risk. Avoid DMSO, ethanol, and strongly alkaline solvents (pH above 8). These are reported as incompatible and can drive degradation rather than clean dissolution. Any solvent-selection decision for a given lot should be confirmed against the batch COA and the supplier’s stated compatible diluents.
  • Add diluent slowly down the vial wall, never onto the cake. Direct the diluent stream down the inner glass wall of the vial with a sterile syringe so it pools and reaches the cake gently, rather than firing a jet straight onto the peptide. A hard stream onto the cake creates high local peptide concentration and mechanical shear at the point of impact, both of which encourage aggregation. Let the diluent contact and begin to wet the cake on its own before any mixing.
  • Dissolve by gentle swirling or by rolling the vial slowly between the palms. Do not vortex, do not shake, and do not invert vigorously. Vigorous mechanical agitation introduces air-liquid interfaces and shear that are reported to promote peptide aggregation, the same failure mode as gelling. Give the material time. Slow dissolution is normal and is not itself a sign of a problem. Target a clear, colorless to very slightly yellow solution.
  • A clear to very faintly yellow solution is the target endpoint. Persistent cloudiness or a gel that does not clear with patience and gentle warming toward roughly 25 to 30 C points away from simple slow dissolution and toward either an incompatible solvent or degradation. If cloudiness persists after gentle warming, treat it as a signal to re-examine the diluent choice and the lot rather than to keep agitating, since more agitation only compounds aggregation.

TESAMORELIN: 10MG

Mix with .5mL (50 units) Acetic Acid until dissolved; then add 2.5mL (250 units) Bacteriostatic Water

Standard Protocol

30 units (1mg), 1x/day, 5 days/week

Maximum Protocol

60 units (2mg), 1x/day, 5 days/ week

TESAMORELIN: 20MG

Mix with 1mL (100 units) Acetic Acid solution until dissolved, then add 4mL (400 units) Bacteriostatic water

Standard Protocol

25 units (1mg) 1x/day, 5 days/week

Maximum Protocol

50 units (2mg) 1x/day, 5 days/week

STACKING SUGGESTIONS

Tesamorelin stacks extremely well with other fat-burning and GH-boosting peptides:

  • AOD-9604 – Targeted fat burning, especially abdominal
  • CJC-1295 / Ipamorelin – Synergistic GH elevation for deeper fat loss and muscle growth
  • GHK-Cu – Tissue regeneration and skin improvement
  • MOTS-C – Boosts metabolic performance and ATP levels
  • SS-31 – Mitochondrial repair and enhanced nerve healing
  • L-Carnitine – Enhances fat metabolism during GH therapy

Fat loss stack: Tesamorelin + AOD-9604 + CJC-1295
Neuroregeneration stack: Tesamorelin + SS-31 + MOTS-C
Aesthetic stack: Tesamorelin + GHK-Cu + CJC-1295